Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells. [electronic resource]
- Journal of periodontology Feb 2004
- 249-59 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-3492
10.1902/jop.2004.75.2.249 doi
1-Methyl-3-isobutylxanthine--pharmacology Adolescent Adult Bucladesine--pharmacology Carrier Proteins--drug effects Cells, Cultured Colforsin--pharmacology Cyclic AMP-Dependent Protein Kinases--antagonists & inhibitors Cyclooxygenase Inhibitors--pharmacology Dinoprostone--pharmacology Female Humans Interleukin-1--pharmacology Ligands Male Membrane Glycoproteins--drug effects NF-kappa B--drug effects Osteoclasts--drug effects Periodontal Ligament--drug effects Phosphodiesterase Inhibitors--pharmacology Protein Kinase C--antagonists & inhibitors RANK Ligand RNA, Messenger--drug effects Receptor Activator of Nuclear Factor-kappa B Receptors, Prostaglandin E--agonists Receptors, Prostaglandin E, EP2 Subtype Receptors, Prostaglandin E, EP4 Subtype